Form 8-K - Current report:
SEC Accession No. 0001753926-25-000211
Filing Date
2025-02-11
Accepted
2025-02-11 09:28:38
Documents
57
Period of Report
2025-02-11
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K g084697_8-k.htm   iXBRL 8-K 38720
2 EXHIBIT 99.1 g084697_ex99-1.htm EX-99.1 13750
3 EXHIBIT 99.2 g084697_ex99-2.htm EX-99.2 20836
4 EXHIBIT 99.3 g084697_ex99-3.htm EX-99.3 26353
5 GRAPHIC img001_v1.jpg GRAPHIC 11482
9 GRAPHIC image_001.jpg GRAPHIC 2798
10 GRAPHIC img001_v3.jpg GRAPHIC 759669
11 GRAPHIC img002_v3.jpg GRAPHIC 1151893
12 GRAPHIC img003_v3.jpg GRAPHIC 712269
13 GRAPHIC img004_v3.jpg GRAPHIC 393645
14 GRAPHIC img005_v3.jpg GRAPHIC 730202
15 GRAPHIC img006_v3.jpg GRAPHIC 631865
16 GRAPHIC img007_v3.jpg GRAPHIC 783730
17 GRAPHIC img008_v3.jpg GRAPHIC 685563
18 GRAPHIC img009_v3.jpg GRAPHIC 586171
19 GRAPHIC img010_v3.jpg GRAPHIC 607892
20 GRAPHIC img011_v3.jpg GRAPHIC 281541
21 GRAPHIC img012_v3.jpg GRAPHIC 694039
22 GRAPHIC img013_v3.jpg GRAPHIC 751004
23 GRAPHIC img014_v3.jpg GRAPHIC 396571
24 GRAPHIC img015_v3.jpg GRAPHIC 492583
25 GRAPHIC img016_v3.jpg GRAPHIC 348119
26 GRAPHIC img017_v3.jpg GRAPHIC 430487
27 GRAPHIC img018_v3.jpg GRAPHIC 534323
28 GRAPHIC img019_v3.jpg GRAPHIC 682698
29 GRAPHIC img020_v3.jpg GRAPHIC 368559
30 GRAPHIC img021_v3.jpg GRAPHIC 665282
31 GRAPHIC img022_v3.jpg GRAPHIC 684165
32 GRAPHIC img023_v3.jpg GRAPHIC 317488
33 GRAPHIC img024_v3.jpg GRAPHIC 689825
34 GRAPHIC img025_v3.jpg GRAPHIC 698203
35 GRAPHIC img026_v3.jpg GRAPHIC 740259
36 GRAPHIC img027_v3.jpg GRAPHIC 752865
37 GRAPHIC img028_v3.jpg GRAPHIC 694164
38 GRAPHIC img029_v3.jpg GRAPHIC 729888
39 GRAPHIC img030_v3.jpg GRAPHIC 458933
40 GRAPHIC img031_v3.jpg GRAPHIC 619573
41 GRAPHIC img032_v3.jpg GRAPHIC 696938
42 GRAPHIC img033_v3.jpg GRAPHIC 690255
43 GRAPHIC img034_v3.jpg GRAPHIC 705462
44 GRAPHIC img035_v3.jpg GRAPHIC 583915
45 GRAPHIC img036_v3.jpg GRAPHIC 707175
46 GRAPHIC img037_v3.jpg GRAPHIC 480184
47 GRAPHIC img038_v3.jpg GRAPHIC 582432
48 GRAPHIC img039_v3.jpg GRAPHIC 752865
  Complete submission text file 0001753926-25-000211.txt   33739377

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE lipo-20250211.xsd EX-101.SCH 3012
7 XBRL LABEL FILE lipo-20250211_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE lipo-20250211_pre.xml EX-101.PRE 22357
59 EXTRACTED XBRL INSTANCE DOCUMENT g084697_8-k_htm.xml XML 3739
Mailing Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208
Business Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208 412-901-0315
LIPELLA PHARMACEUTICALS INC. (Filer) CIK: 0001347242 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41575 | Film No.: 25607921
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)